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A NovelLysosome-Associated Membrane Glycoprotein,
DC-LAMP, Induced upon DC Maturation, Is Transiently
Expressed in MHC Class II Compartment
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primary T cell response (Inaba et al., 1983; Inaba and
Steinman, 1985). The lack of IDC-specific marker has
hampered their characterization. They are phenotypi-
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bound to the released ab dimers. Another molecule,
HLA-DM, which is predominantly located in the MHC
class II compartment (MIIC) in human B cells and imma-Summary
ture DC (Peters et al., 1991; Karlsson et al., 1994; Ruden-
sky et al., 1994; Sanderson et al., 1994; Tulp et al., 1994;We have identified a novel lysosome-associated mem-
West et al., 1994; Nijman et al., 1995), facilitates thebrane glycoprotein localized on chromosome 3q26.3-
exchange of the residual CLIP with antigen-derived pep-q27, DC-LAMP, which is homologous to CD68. DC-
tides to be loaded on class II molecules (Martin et al.,LAMP mRNA is present only in lymphoid organs and
1996; Miyazaki et al., 1996). Class II±peptide complexesDC. A specific MAb detects the protein exclusively in
are then transported to the cell surface, where they caninterdigitating dendritic cells. Expression of DC-LAMP
be recognized by the TCR-CD4 complexes on T cells.increases progressively during in vitro DC differentia-
Thus, multiple subcellular compartments that could betion, but sharply upon activation with LPS, TNFa, or
correlated to different stages of DC maturation are in-CD40L. Confocal microscopy confirmed the lysosomal
volved in the loading of peptide on class II moleculesdistribution of the protein. Furthermore, DC-LAMP
(Pierre et al., 1997).was found in the MHC class II compartment immedi-
In the search for novel molecules restricted to DC, weately before the translocation of MHC class II mole-
identified a member of the lysosome-associated mem-cules to the cell surface, after which it concentrates
brane glycoprotein family (LAMP), which we named DC-into perinuclear lysosomes. This suggests that DC-
LAMP. This molecule is most homologous to CD68 (Hol-LAMP might change the lysosome function after the
ness and Simmons, 1993), a lysosomal glycoproteintransfer of peptide±MHC class II molecules to the sur-
mainly expressed by macrophages and platelets, whichface of DC.
might be involved in endocytosis and/or lysosomal traf-
fic. As DC-LAMP could only be detected in IDC, it repre-Introduction
sents the first marker specific for these mature DC. We
demonstrate here that DC-LAMP, which appears duringDendritic cells (DC), which are widely distributed through-
DC maturation, localizes in the MIIC, where peptidesout the body, are the most potent antigen-presenting
associate with class II molecules. According to the cellu-cells (APC) particularly involved in the initiation of Ag-
lar and subcellular distribution of DC-LAMP, we proposespecific immune responses (Steinman, 1991; Bancher-
a role for this novel lysosomal protein in the remodelingeau and Steinman, 1998). Immature DC, such as the
of specialized antigen-processing compartments and inepidermal Langerhans cells, capture antigens with high
MHC class II±restricted Ag presentation.efficiency. Upon inflammatory stimuli, DC migrate from
the periphery to the lymphoid organs, home to the
T-dependent areas, and activate naive T cells. Along Results
their migration, DC mature from an antigen-uptake/pro-
cessing phenotype, typical of immature DC spread in Identification of a Novel Member of the LAMP
nonlymphoid tissues, to the distinctive antigen-pre- Family in Dendritic Cells
senting phenotype of interdigitating dendritic cells (IDC) A novel 0.7 kb partial cDNA (E02B02) was isolated by
gathered in lymphoid tissues (Steinman, 1991; Austyn, screening a CD1a1-derived DC subtraction library. North-
ern blots probed with the E02B02 clone showed a 3.2
kb mRNA transcript strongly expressed in dendritic cells# To whom correspondence should be addressed (e-mail: serge.
lebecque@sch-plough.fr). but not in CHA, the driver epithelial cell line used for
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Figure 1. Nucleotide and Amino Acid Sequences of DC-LAMP
(A) Human DC-LAMP cDNA nucleotide sequence and deduced amino acid sequence. The N-terminal signal peptide is underlined by a dotted
line. Sequences corresponding to the serine/proline hinge region, the transmembrane region, and the cytoplasmic tail are underlined in bold.
Potential N-linked glycosylation sites (N-X-S/T) and the polyadenylation signal are underlined.
(B) Alignment of DC-LAMP amino acid sequence with other members of the LAMP family. A multiple alignment of members of the LAMP
family was created using the Megalign program with Clustal method on the LASERGENE Navigator (DNASTAR, Madison, WI).
subtraction. The full-length 3155 bp cDNA sequence Simmons, 1993), a DC/macrophages marker, followed
by thehuman LAMP-1 (23%) and LAMP-2 (21%) (Fukudawas obtained by RACE: it contains a 59 untranslated
sequence (nt 1±42), a 1248 bp open reading frame (nt et al., 1988) (Figure 1B). A phylogenic tree (Figure 2A)
illustrates the conservation of amino acid sequences of43±1290) starting with a methionine codon situated in a
consensus Kozak sequence, a 39 untranslated sequence the different LAMP proteins between different species.
The intraluminal portion of the LAMP proteins is madeof 1865 nucleotides (nt 1291±3155), and a polyadeny-
lation signal AATAAA at position 3138 followed by a of two domains separated by a serine/proline-rich hinge
region. Each domain of LAMP-1 and LAMP-2 containspoly(A) tail. The predicted polypeptide sequence of 416
amino acids has the typical features of a type I integral four cysteines that form two disulfide bridges. In con-
trast, only the membrane-proximal domains (domain II)membrane protein. It has a presumptive amino-terminal
signal peptide of 21 residues, followed by a long extra- of CD68 and DC-LAMP contain four cysteines and prob-
ably two disulfide bounds (Figures 1B and 2B). Separatecellular domain (381 residues), a hydrophobic trans-
membrane domain (25 residues), and a short cyto- amino acid alignments of domain I (membrane distal
domain) or domain II showed that DC-LAMP shares 28%plasmic domain (10 residues). The sequence indicates
that there areseven potential N-glycosylation sites (Asn- and 31% identity, respectively, with CD68, 18% and
27% with LAMP-1, and 18% and 25% with LAMP-2.X-Ser/Thr) and several putative O-glycosylation sites
(stretches of proline, serine, and threonine) (Figure 1A). Therefore, LAMP domain II regions are more conserved
among LAMP family members than domain I regions.The DC-LAMP gene was mapped by in situ hybridiza-
tion, using a fluorescent probe, on the 3q26.3-q27 bands Domain I of DC-LAMP and CD68 has several serine,
threonine, and proline residues and therefore couldof the long arm of chromosome 3 (Mattei et al., 1990).
Sequence comparison with the EMBL databases re- be considered as a mucin-like protein covered with
O-linked glycans (Holness and Simmons, 1993). Further-vealed homology with lysosomal glycoproteins from the
LAMP family and, therefore, E02B02 was named DC- more, DC-LAMP has the short cytoplasmic tail with a
glycine-tyrosine motif, which characterizes all knownLAMP. The predicted amino acid sequence showed the
closest homology (29%) with human CD68 (Holness and LAMP family members.
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Figure 2. Phylogenic and Structural Relation-
ships between the LAMP Family Members
(A) Phylogenic relationship of LAMP pro-
teins from different species. Amino acid se-
quences were compared using the Megalign
program and then displayed graphically in a
phylogenetic tree. Units indicate the number
of substitution events. Abbreviations: h, hu-
man; r, rat; Ham, hamster; bov, bovine; m,
mouse; ch, chicken.
(B) Domain organization of hLAMP-1,
hLAMP-2, hCD68, and hDC-LAMP.N-glycans
and O-glycans are indicated by tridents and
Ys, respectively. Each loop is made by a di-
sulfide bond. The majority of the molecule
resides in the luminal side of lysosomes. The
structure depicted is adapted from Fukuda,
1991.
Thus, by the search for novel DC molecules, we identi- freshly isolated cells, DC-LAMP was only present in rest-
ing or PMA-ionomycin activated DC, but not in activatedfied a member of the lysosome-associated membrane
glycoprotein similar to CD68. monocytes, T cells, granulocytes, PBL and B cells (Fig-
ure 3B). Identical results were obtained by RT±PCR with
the same cell lines and the cells isolated ex vivo (data notDC-LAMP mRNA Is Specifically Expressed
in DC and Is Up-Regulated after shown), therefore confirming the restriction of cellular
distribution to DC. Semiquantitative RT±PCR was nextDC Activation or Maturation
When expression of DC-LAMP mRNA was studied in used to follow DC-LAMP gene transcription. During the
culture of CD341 human cord blood progenitors in thenormal human tissues, a strong single band of 3.2 kb
was detected by Northern blot in appendix, thymus, presence of GM-CSF and TNFa, DC-LAMP mRNA was
hardly detected at day 6, but abundant at day 12. Furtherlymph node, and lung (adult and fetal), and a much
weaker signal was found in spleen (Figure 3C; data not up-regulation was observed after triggering final matu-
ration of the DC by 4 days of coculture with hCD40L-shown). No messenger was observed in bone marrow,
pancreas, placenta, brain, heart, or peripheral blood leu- transfected L cells (Figure 3D). Similarly, while mono-
cytes do not express a detectable amount of DC-LAMPkocytes. When cell lines were analyzed, DC-LAMP was
abundant in DC, scarce in PMA-ionomycin activated mRNA, a faint band could be amplified after 6 days of
culture in the presence of GM-CSF and IL-4. Again,Jurkat T cells and JY lymphoblastoid B cells, and absent
in myelo-erythrocytic TF1 cells, kidney carcinoma CHA following activation of these monocyte-derived DC
through CD40, the level of mRNA sharply increasedcells, and lung fibroblast MRC5 cells (Figure 3A). Among
Immunity
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Figure 3. Analysis of DC-LAMP mRNA Ex-
pression
(A) Northern blot analysis of DC-LAMP ex-
pression in 20 mg RNA prepared from various
PMA-ionomycin-activated human cell lines
and CD341-derived DC.
(B) Northern blot analysis of DC-LAMP ex-
pression in 20 mg RNA prepared from freshly
isolated cells. Monocytes, granulocytes, and
B cells were a pool of nonactivated, 1, and
6 hr PMA-ionomycin-activated cells. DC, T
cells, and PBLwere activated with PMA-iono-
mycin for 1 and 6 hr.
(C) Commercially available poly(A)1 Northern
blots of a variety of human lymphoid tissues
(Clontech 7754±1) probed with DC-LAMP.
(D) RT±PCR analysis of DC-LAMP expression
on different types of DC generated in vitro.
RT±PCR was carried under standard condi-
tions starting with 5 ng cDNA for 35 cycles.
Control b-actin RT±PCR was performed with
the same cDNA. cDNA was purified from DC
generated in vitro from CD341 progenitors
cultured in the presence of GM-CSF and
TNFa for 6 and 12 days and for an additional
4 days with CD40L L cells (Day 16), or from
monocytes cultured in the presence of GM-
CSF and IL-4 for 6 days with or without 3, 12,
and 24 hr activation with CD40L L cells.
within 3 hr and reached a maximum after 12 hr (Fig- present in germinal centers, as well as the few macro-
phages found in the T cell areas coexpressed DC-LAMPure 3D). Weak transcription of DC-LAMP was found
(blue). Indeed, the staining with DC-LAMP and CD68in CD41CD11c1CD32 germinal center dendritic cells
appeared mutually exclusive (Figure 4Bd).(GCDC) freshly isolated from tonsils, which could be
Thus, the staining pattern in a range of human lym-enhanced by either PMA-ionomycin or CD40L activa-
phoid tissues is consistent with DC-LAMP being ex-tion, and in freshly isolated Langerhans cells (data not
pressed solely in IDC.shown). PMA-ionomycin-activated macrophages gen-
erated in vitro, LPS-activated monocytes, and CD40L-
DC-LAMP Protein Expression Increases Progressivelyactivated B cells also weakly express DC-LAMP mRNA.
during DC Differentiation and Is SharplyIn conclusion, DC-LAMP appears to be increasingly
Up-Regulated during DC Maturationtranscribed upon maturation/activation signals in DC.
To extend RT±PCR data regarding the transcription of
DC-LAMP, we next used our specific MAb to analyzeDC-LAMP MAb Stains Exclusively IDC
by FACS the presence of the protein during DC develop-on Human Lymphoid Tissues
ment and maturation. In agreement with the predictedWe next directly determined which cells express DC-
lysosomal localization of the protein, DC-LAMP wasLAMP protein in vivo by staining human lymphoid tissue
barely detectable at the cell surface, while intracellularsections with a mouse anti-DC-LAMP MAb raised
staining was observed.against the recombinant DC-LAMP-Fc chimera. Double
Kinetic analysis during CD341-derived DC culture
staining of tonsil sections with anti-CD3 MAb (red)
showed that DC-LAMP is present from day 12 and pro-
showed that the DC-LAMP1 cells (blue) are large, inter-
gressively increases up to day 14 (Figure 5A). Of note,
digitated cells exclusively localized in the T cell areas, DC-LAMP up-regulation coincides with the highest level
but not in B cell follicles (Figure 4Aa). Likewise, on of surface HLA class I and II, CD83, CD80, and CD86 that
spleen, lymph node, and medulla of thymus tissue sec- characterizes mature DC (Figure 5A; data not shown).
tions, DC-LAMP1 cells are only found in T cell areas Furthermore, signals inducing DC maturation such as
(Figures 4Ab, 4Ac, and 4Ad). In small intestine, DC- TNFa, CD40L, or LPS (data not shown) significantly in-
LAMP1 cells are observed in T cell areas corresponding crease both the percentage of DC-LAMP1 DC (45%±
to Peyer's patches (Figure 4Ae). In contrast, neither epi- 70%) and the intensity of the staining (MFI, 693±1022)
dermal CD1a1 (red) Langerhans cells nor CD1a2 dermal (Figure 5B). However, even after a prolonged maturation
DC express DC-LAMP (Figure 4Af). On tonsil sections, signal, a small fraction of CD341-derived DC does not
the large DC-LAMP1 cells present in T cell areas (Figure express DC-LAMP, most likely reflecting a lack of syn-
4Ba) expressed high levels of CD40 (DC-LAMP, blue; chronization in their stage of differentiation. Unactivated
CD40, red) (Figure 4Bb), and most of them were also monocyte-derived DC (day 6) do not contain DC-LAMP,
CD831 (CD83, red; DC-LAMP, blue), demonstrating that whereas 96 hr TNFa, LPS, or CD40L activation induces
they most likely represent IDC (BjoÈ rck et al., 1997) (Fig- a strong DC-LAMP staining in60%±100% of the cells (Fig-
ure 4Bc). Interestingly, none of the CD681 cells (red), ures 5B and 5C). As shown in Figure 5C, DC-LAMP ap-
pears rapidly after LPS activation of monocyte-derivedincluding the tingible body macrophages and the GCDC
A DC-Specific Lysosome-Associated Glycoprotein
329
Figure 4. Immunohistological Characterization of DC-LAMP Expression on Human Lymphoid Organs and Skin Tissue Section
(A) Localization of DC-LAMP1 cells on different human tissue sections: tonsil (a), spleen (b), lymph node (c), medulla of thymus (d), small
intestine (e), and skin (f). Anti-CD3 (red) and anti-DC-LAMP (blue) double staining identifies DC-LAMP1 cells localized in T cell areas of the
lymphoid organs (a±e) (a and d: original magnification, 1003; b, c, and e: 2003). In skin section (f), anti-CD1a (red) and anti-DC-LAMP (blue)
double staining identifies CD1a1 Langerhans cells that do not express DC-LAMP (original magnification 4003).
(B) Phenotypic characterization of DC-LAMP1 cells on human tonsil sections. Double staining identifies large DC-LAMP1 cells (blue) localized
in T cell areas (CD3, red) (a). DC-LAMP1 cells are CD401 (red) (b), and most of them coexpressing CD83 (red) are purple, (c) but they do not
express CD68 (red) (d) (magnification 4003). CD681 DC-LAMP2 cells in germinal centers are probably tingible body macrophages (d).
Immunity
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Figure 5. Regulation of DC-LAMP Expres-
sion during DC Maturation
DC-LAMP expression was analyzed by cyto-
fluorimetry. DC-LAMP phenotype was studied
after DC permeabilization in saponin, as de-
scribed in Experimental Procedures, whereas
CD86 was stained on the surface. Results are
representative of four experiments.
(A) Kinetic of intracytoplasmic DC-LAMP
expression during CD341-derived DC matu-
ration. DC maturation was followed by CD86-
PE cell surface staining. Gray overlap histo-
grams show negative fluorescence controls
with an isotype-matched MAb of unrelated
specificity.
(B) Different modes of activation induce DC-
LAMP expression on both monocyte- and
CD341-derived DC. Flow cytometric analysis
was performed on day 12 CD341-derived DC
and after 48 hr TNFa or CD40L L cell activa-
tion. Monocyte-derived DC were analyzed at
day 6 and after 96 hr of TNFa, LPS, or CD40L
activation. Results are indicated in percent of
DC-LAMP1 cells.
(C) Kinetic of intracytoplasmic DC-LAMP and
CD68 expressions during monocyte-derived
DC maturation with LPS (2±72 hr). DC matura-
tion was followed by CD86-FITC cell surface
staining. Gray overlap histograms show neg-
ative fluorescence controls with a MAb of un-
related specificity. Results are indicated in
MFI (mean fluorescence intensity).
DC; maximal staining is observed within 6 hr of LPS upon activation. DC-LAMP, which is absent at immature
stages (Figure 7A), appears in the MIIC at an intermedi-activation and correlates with up-regulation of CD86, a
ate stage of DC maturation (5±6 hr LPS) (Figure 7B).good marker of DC maturation. Interestingly, we found
Again, after full maturation (24±96 hr LPS), all intracellu-that CD68, the gene most homologous to DC-LAMP, is
lar MHC class II molecules are translocated to the cellexpressed at an early stage of DC differentiation and is
surface, and DC-LAMP is condensed into perinucleardown-regulated upon maturation on either monocyte-
lysosomes coexpressing high levels of LAMP-1 (Figureand CD341-derived DC (Figure 5C; data not shown).
7C). At both stages of maturation (intermediate-mature),Taken together, these results show that DC-LAMP
DC-LAMP colocalizes with LAMP-1 (Figures 7E and 7F).protein is rapidly up-regulated upon DC maturation.
Soluble antigens captured by DC transit through the
MIIC (Nijman et al., 1995). We therefore performed aDC-LAMP Is Transiently Expressed in the MIIC
FITC-Dextran uptake for 1 hr at 378C on nonactivatedTo analyze the subcellular localization of DC-LAMP, we
or for 6 hr on LPS-activated monocyte-derived DC. As
have studied different stages of DC maturation by confo-
expected, immature DC capture high levels of FITC-
cal microscopy. The DC-LAMP signal is absent or very
Dextran but do not express DC-LAMP, while class II
weak at the immature stage of CD341-derived DC matu-
molecules are still intracellular (Figures 8A and 8D). After
ration (day 10±11), when most of the MHC class II mole- 6 hr of LPS activation, DC-LAMP appears and colocal-
cules are still intracellular and when the homologous izes with FITC-Dextran, establishing that DC-LAMP1
lysosomal marker, CD68, is highly expressed (Figure 6; vesicles intersect with the endosomal compartment. At
data not shown). DC-LAMP appears first duringªsponta- this intermediate stage of maturation, DC-LAMP is pres-
neousº maturation of DC (day 12) within vesicles spread ent in MHC class II1 vesicles (Figure 7B), which also
throughout the whole cell that contain MHC class II contain HLA-DM (Figure 8C) and display an acidic pH
molecules, LAMP-1, LAMP-2, CD68, cathepsin D, and revealed by the accumulation of the lysotracker mole-
HLA-DM (Figure 6; data not shown). These vesicles cor- cules (Figure 8F). Those observations are in agreement
respond to the previously described MIIC (Peters et al., with the FACS data reported above.
1991). After CD40L activation, DC-LAMP accumulates Collectively, these results revealed that DC-LAMP ap-
into more central and larger vesicles, which are class pears transiently in theMIIC just before the translocation
II2, LAMP-11 and LAMP-21. Meanwhile, CD68 progres- of class II molecules to the cell surface and next concen-
sively disappears. At the final stage of DC maturation, trates into perinuclear lysosomes.
while all MHC class II molecules are exported to the cell
surface, DC-LAMP is only concentrated with LAMP-1 Discussion
and LAMP-2 in perinuclear lysosomes (Figure 6; data
not shown). Kinetic analysis in monocyte-derived DC is Dendritic cells constitute an heterogenous population
of cells, present at trace level in all tissues. Few markersfacilitated by a tighter synchronization of DC maturation
A DC-Specific Lysosome-Associated Glycoprotein
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Figure 6. Analysis by Confocal Microscopy of the Subcellular Localization of DC-LAMP during the Maturation of CD341 Derived DC
Double-color confocal microscopy analysis of HLA-DR (green) and DC-LAMP (red) was performed on immature (day 10±11), intermediate (day
12), and fully mature (24 hr CD40L activation) CD341-derived DC. The superposition between the two fluorochromes (yellow color with arrows)
is indicative of the colocalization of class II molecules and DC-LAMP in the same vesicles.
exist for the characterization of DC subtypes. We report luminal domain, a single transmembrane region, and a
short cytoplasmic tail of 10±11 amino acids (Fukuda,here the identification of a novel member of the LAMP
family, called DC-LAMP, which is specifically expressed 1991). As for the other LAMP members, 90% of DC-
LAMP protein should be located in the lumen of lyso-by a subset of DC, the interdigitating dendritic cells
(IDC). On the basis of sequence and domain homologies, somes, and the intraluminal portion can be divided in
two domains by a serine/proline-rich hinge region (Fu-DC-LAMP is clearly a member of the LAMP family of
lysosomal associated glycoproteins. Common struc- kuda et al., 1988). DC-LAMP and CD68 share very similar
predicted structure and are the only two members oftural features of this family include a molecular mass of
90±120 kDa, a polypeptide core of z40 kDa, a high this LAMP family with a single membrane-proximal (do-
main II) lamp-like domain, where the highly conservednumber (7±20) of N-linked glycosylation sites in their
Figure 7. Analysis by Confocal Microscopy of the Subcellular Localization of DC-LAMP during Maturation of Monocyte-Derived DC
Triple-color confocal microscopy analysis of HLA-DR (green), DC-LAMP (red) (A, B, and C) and LAMP-1 (red) (D, E, and F) was performed on
unactivated (0 hr LPS) monocyte-derived DC or after 6 and 24 hr LPS activation. The superposition between two fluorochromes (yellow color)
is indicative of the colocalization of class II molecules and DC-LAMP or LAMP-1 in 6 hr activated monocyte-derived DC.
Immunity
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Figure 8. Characterization by Confocal Microscopy of the DC-LAMP1 Compartment on LPS-Activated Monocyte-Derived DC
FITC-Dextran uptake for 1 hr at 378C was performed with 0 or 6 hr LPS-activated monocyte-derived DC. Double staining of these cells was
realized with DC-LAMP (red) (A and B) and HLA-DR (red) (D and E). The superposition between the two fluorochromes (yellow color) indicates
that the DC-LAMP1 HLA-DR1 compartment intersects with FITC-Dextran loaded vesicles in 6 hr LPS-activated monocyte-derived DC.
6 hr LPS-activated monocyte-derived DC (see Figure 7B for HLA-DR and DC-LAMP on the same cells) were stained with HLA-DR (green) and
HLA-DM (red) (C) or lysotracker (red) (F). The superposition between the two fluorochromes (yellow color) is indicative of a colocalization of
class II molecules and HLA-DM in the acidic MIIC.
cysteines form disulfide bounds that probably stabilize but, up to now, very few MAbs are truly DC specific.
Immature, epithelial Langerhans cells are characterizedthe protein (Fukuda, 1991). In their N-terminal portion
(domain I), CD68 and DC-LAMP contain a region rich in by expression of CD1a (Fithian et al., 1981), Lag (Kashi-
hara et al., 1986), and Langerin, a protein recently identi-serines and threonines, which may bear O-linked glycan
chains and is thereforeconsidered as a mucin-like struc- fied in our laboratory (unpublished data), but they lack
DC-LAMP. In contrast, immunohistological analysisture (Holness and Simmons, 1993). Preliminary immuno-
precipitation studies revealed that, like the other mem- shows DC-LAMP to be an IDC-specific marker. IDC are
mature DC located in T cell areas of lymphoid tissues,bers of the family, DC-LAMP is highly glycosylated: the
observed mass of the mature glycoprotein on SDS- characterized by a strong expression of MHC class II
molecules, a low Ag uptake capacity, and a potentabilityPAGE is around 70±90 kDa (data not shown), whereas
the predicted mass for the polypeptide core is 44 kDa. to stimulate naive T cells (Steinman, 1991). They express
a set of markers shared by other cells, including a highThe extensive glycosylation of LAMP molecules is
thought to be important for protecting the polypeptide level of MHC class II, CD80, CD86, and CD40, as well
as CD83 (Zhou et al., 1992; BjoÈ rck et al., 1997), and p55cores from proteolytic degradation within the lysosome
(Barriocanal et al., 1986). Another conserved feature of (Mosialos et al., 1996). The correlation between DC-
LAMP expression and DC maturation was directly estab-LAMP molecules, a short cytoplasmic tail with a GY
motif, essential for adressing the LAMP molecules to lished by in vitro studies. While DC-LAMP is absent
in immature DC (day 8 CD341-derived DC, monocyte-lysosomes, is also present in DC-LAMP (Williams and
Fukuda, 1990; Harter and Mellman, 1992). Despite their derived DC), it is rapidly up-regulated (3±9 hr in mono-
cyte-derived DC) upon maturation induced by TNFa,structural homology and thehigh degree of conservation
across different species, members of the LAMP family LPS, or CD40L. Moreover, detection of DC-LAMP corre-
lates with strong expression of CD86 and surface MHCare located on different chromosomes: human LAMP-1,
LAMP-2, CD68, and DC-LAMP are mapped on chromo- class II molecules, which are both features of the end
stage of DC maturation. While DC-LAMP MAb stainssomes 13q34, Xq24±25 (Mattei et al., 1990), 17p13, and
3q26±27, (D.R. Greaves, personal communication), re- exclusively IDC on tissue sections, a low level of DC-
LAMP mRNA expression could be induced upon activa-spectively. This suggests that these proteins diverged
relatively early in the evolution, probably acquiring dis- tion in vitro in other APC types (monocytes, macro-
phages, and B cells), further suggesting a role for thistinct functions. Of note, to date no monogenic human
disease has been linked to any of the LAMP member novel lysosomal protein in antigen presentation.
The tight control of DC-LAMP expression during DCloci.
DC express a repertoire of molecules common to maturation was confirmed by confocal microscopy, and
a striking distribution of the molecule was observed.other leukocytes and a high level of MHC molecules,
A DC-Specific Lysosome-Associated Glycoprotein
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Early immature DC, which express most of their MHC in some circumstances DC-LAMP could play a similar
role at the DC surface. The reciprocal expression ofclass II molecules intracellularly, could not be stained
with anti-DC-LAMP MAb. DC-LAMP was first detected CD68 and DC-LAMP by DC suggests that despite their
structural homology, these two molecules may serveat an intermediate maturation stage (6 hr LPS) within
small intracellular vesicles spread through the cyto- distinct functions. It has been proposed that through its
mucin-like domain, CD68 could favor an efficient pre-plasm as well as within perinuclear lysosomes. At this
stage of maturation, the peripheral DC-LAMP1 struc- sentation by MHC class II molecules (Rabinowitz and
Gordon, 1991; Holness and Simmons, 1993). Moreover,tures represent acidic vesicles that intersect with the
endosomal compartment and contain MHC class II mol- surface CD68 binds oxidized low-density lipoprotein
(Ramprasad et al., 1996) and shuttles rapidly betweenecules and HLA-DM as well as lysosomal markers
LAMP-1, LAMP-2, and CD68, to a weaker extent. There- the endosomes and the plasma membrane. It also rec-
ognizes phosphatidyl-rich liposomes and may facilitatefore, DC-LAMP first appears in the so-called lysosomal
MHC class II1 compartment (MIIC), which has been ini- the capture of apoptotic bodies. Indeed, despite a very
weak expression at the cell surface, the conserved Ytially described in human B cells (Peters et al., 1991)
and, more recently, in immature DC (Nijman et al., 1995; residue is likely to promote an efficient internalization
of DC-LAMP (Harter and Mellman, 1992).Pierre et al., 1997). The MIIC is thought to be the site of
efficient peptide loading on MHC class II molecules in In conclusion, we have identified a novel member of
the LAMP family, which represents a marker specific tohuman B cells (Rudensky et al., 1994; Tulp et al., 1994;
West et al., 1994). Thus, the appearance of DC-LAMP mature human dendritic cells. The presence of DC-
LAMP in the MIIC in late mature DC indicates that thisparallels the remodeling of the endosome/lysosome
compartment observed during human DC maturation, may serve an important function during the processing
of exogenous antigens. DC-LAMP might also participatereminiscent of a recently published study on mice by
Pierre et al. (1997). Of note, during hourly kinetic study in the functional remodeling of the MIIC by facilitating
the translocation of MHC class II molecules to the cellof human monocyte±derived DC maturation (Figure 7;
data not shown), we have been unable to detect by con- surface. However, direct information about the role of
DC-LAMP will await the analysis of mice deficient forfocal microscopy the nonlysosomal class II1 LAMP-12
vesicles (CIIV), first identified in murine B cells (Ami- this gene.
gorena et al., 1994). Whether this corresponds to a true
difference between human and mouse DC (Pierre et al., Experimental Procedures
1997) will need further investigation. Induction of DC
Hematopoietic Factors, Cells, and Cell Linesmaturation by either LPS or TNFa is accompanied by a
rhGM-CSF, rhTNFa, rhSCF, and rhM-CSF were used at optimal con-transient burst of MHC class II gene transcription, an
centration as described (Caux et al., 1996). rhG-CSF (ED50, 0.01±0.03increase of MHC class II protein half-life, an enhanced
ng/ml; R & D, Abington, UK) was used at an optimal concentrationformation of MHC-class II±peptide complexes, and their
of 25 ng/ml.
prompt transfer to the cell surface (Cella et al., 1997). PBMC and T cells were purified using standard protocols (Bates
Increased proteolytic degradation of Ii by cathepsin fa- et al., 1997). B cells were obtained from human tonsils as described
(Liu et al., 1996). Langerhans cells were prepared from normal skinvors the loading of peptides onto MHC class II (Cress-
by CD1a positive selection. A purity higher than 95% was systemati-well, 1998) molecules and the translocation of these
cally achieved. Germinal center dendritic cells (GCDC) were pre-molecules to the cell surface. Whether the accumulation
pared as previously described (Grouard et al., 1996). The purity of
of DC-LAMP protein in the peripheral MIIC and the pro- GCDC was higher than 97%. GCDC were stimulated either by PMA-
gressive disappearance of CD68 also participate in MHC ionomycin for 3 hr or by an anti-CD40 MAb (10 mg/ml G28±5 MAb;
class II remodeling remains to be established. In any kindly provided by Ed. Clark, University of Washington, Seattle, WA)
for 20 hr.case, at later stages of DC maturation, theMIIC vanishes
Granulocytes and macrophages were generated in vitro fromas all the MHC class II molecules move to the cell surface
CD341 progenitors in the presence of G-CSF and SCF for 12 days,(Cella et al., 1997; Pierre et al., 1997), while DC-LAMP,
and M-CSF and SCF for 12 days, respectively. Cells were eitherLAMP-1, and LAMP-2 (Fukuda et al., 1988; Williams and
nonactivated or activated by PMA-ionomycin for 1 and 6 hr (PMA,
Fukuda, 1990), which all contain the conserved GY lyso- 1 ng/ml; Sigma, St Louis, MO) (ionomycin, 1 mg/ml; Calbiochem, La
somal targeting motif, concentrate into perinuclear lyso- Jolla, CA) andpooled. The TF1,Jurkat, MRC5, JY,and U937 cell lines
were obtained from the American Type Culture Collection (ATCC,somes.
Rockville, MD). CHA is an epithelial kidney carcinoma cell line kindlyComparison with other LAMP proteins may provide
provided by C. Bain (Centre LeÂ on BeÂ rard, Lyon, France). All celladditional clues regarding the functions of DC-LAMP.
lines stimulated by PMA-ionomycin for 1 and 6 hr were pooled.LAMP-2 has been described as a receptor for selective Murine fibroblasts transfected with human CD40 ligand (CD40L L
uptake and degradation of cytoplasmic proteins within cells) were produced in the laboratory. All cell types were cultured
lysosomes (Cuervo and Dice, 1996). As only the GY in complete RPMI 1640 (GIBCO BRL, Gaithersburg, MD) (Caux et
al., 1996).motif is conserved between the rat LAMP-2 cytosolic
12 amino acid sequence implicated in this uptake and
DC-LAMP, it is unlikely that DC-LAMP will have a similar Generation of DC from CD341 Cells and from Monocytes
Isolation of CD341 progenitors from umbilical cord blood samplesfunction. LAMP-1, LAMP-2, and CD68 are mostly found
was achieved using Minimacs separation columns (Miltenyi Biotecin lysosomes, but they can also be detected at the cell
GmbH, Bergish Gladbach, Germany). Cultures of CD341 cells weresurface, especially of tumor cells (Lippincott-Schwartz
established in the presence of SCF, GM-CS,F and TNFa as de-
and Fambrough, 1987; Ramprasad et al., 1996). Their scribed (Caux et al., 1996). At day 12±17, 70%±90% of cells were
highly glycosylated domain has been implicated in bind- CD1a1 DC. Monocytes were purified by immunomagnetic depletion
ing to extracellular lectins and in cell migration (Saitoh (Dynal, Oslo, Norway) after preparation of PBMC, followed by a 52%
Percoll gradient. Monocyte-derived DC were produced by culturinget al., 1992; Garrigues et al., 1994). It isunknown whether
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purified monocytes for 6 days in the presence of GM-CSF and IL-4 tonsil sections were also stained using mouse IgG1 anti-CD40 (MAb
89, produced in our laboratory), saturated for 10 min with 10%(Sallusto and Lanzavecchia, 1994). Cells were activated with LPS
(Sigma) at the concentration of 25 ng/ml for 1±72 hr. mouse serum, and stained again using mouseanti-DC-LAMP-biotin.
Skin sections were stained using mouse Ig2b anti-CD1a (Becton
Dickinson, Mountain View, CA) together with anti-DC-LAMP. ThecDNA Libraries and Isolation of the E02B02 cDNA Clone
binding of mouse IgG1 antibodies was revealed by sheep anti-Total RNA was isolated from PMA-ionomycin activated CD1a1
mouse IgG1 (The Binding Site, Birmingham, UK), followed by incuba-CD142-derived DC (at day 12 of the culture) (Caux et al., 1996)
tion with alkaline phosphatase coupled to mouse antibodiesspecificand from PMA-ionomycin-activated CHA cell line following standard
for alkaline phosphatase (APAAP complexes, Dako). The binding ofprocedures. RNA was treated with DNase I before mRNA purification
mouse IgG2a, IgG2b, and IgG3 antibodies were respectively re-using the Oligotex-dT kit (Qiagen GmbH, Hilden, Germany). PolyA1
vealed by biotinylated sheep anti-mouse IgG2a, IgG2b, and IgG3RNA (2 mg) was used to make a cDNA library in the pSport vector
(The Binding Site), followed by ExtrAvidin-peroxidase (Sigma). Alka-(Superscript Plasmid System Kit, GIBCO BRL). A library subtraction
line phosphatase activity was developed by the Fast Blue substratecDNA was performed as described (Bates et al., 1997). In this proto-
(Sigma), whereas peroxydase activity was developed by 3-amino-col, the tracer (subtracted) was the CD1a1-derived DC cDNA, and
9-ethylcarbazole (Sigma).the driver (subtractive) was CHA cDNA. A 0.7 kb cDNA containing
a poly(A) tail was isolated from the CD1a1-derived DC subtraction
library. Cytofluorimetric Analysis of Intracellular
The full-length cDNA of this gene was amplified using the RACE and Cell Surface Phenotype
Marathon kit (Clontech, Palo Alto, CA) and two oligonucleotides, 59- For intracellular staining, cells were incubated with mouse IgG1 anti-
TATTTGATGCCTTCATCTTTACAGCCCA (NGSP1) and 59-CACTCAA DC-LAMP (10 mg/ml) for 30 min at 48C in the presence of permeabili-
GAAAGAACAGTTGGTTAGCGA (GSP1), with the recommended cy- zation medium (0.1% saponin and 1% SVF). After two washes, cells
cling program 1. PCR products were cloned in the pCRII plasmid were incubated with FITC-goat anti-mouse Ig (Dako). Single-color
(Invitrogen, San Diego, CA) and sequenced using a Taq Dye Deoxy surface immunofluorescence was performed according to standard
Terminator Cycle Sequencing kit (Applied Biosystems, Foster City, techniques using FITC-CD86 or PE-CD86 (Pharmingen). Negative
CA) and an automated sequencer (Applied Biosystems). controls were performed with unrelated isotype-matched murine
MAbs. Fluorescence was analyzed with a FACScan flow cytometer
Northern Blot Analysis and RT±PCR (Becton Dickinson, Mountain View, CA).
Northern blots were performed with total RNA (20 mg) hybridized
with the original cloned 722 bp fragment labeled by random priming
Confocal Microscopywith [32P]dCTP, as described (Bates et al., 1997). Multiple human
Intracellular immunofluorescence staining was conducted as pre-adult and fetal tissue blots (Clontech) were similarly used. For RT±
viously described (Rovere et al., 1998). On polylysin-coated cov-PCR, total RNA was reverse transcribed using random hexamer
erslips, cells fixed for 15 min with 4% paraformaldehyde in PBSprimers (Pharmacia, Upsalla, Sweden) and the Superscript RNase-H
were washed twice in 10 mM glycine in PBS and twice in PBSreverse transcriptase (GIBCO BRL). PCR was performed in a DNA
and permeabilized with 0.5% saponin-1% BSA-PBS for 30 min.thermal cycler (Perkin Elmer) for 35 cycles (1 min denaturation at
Coverslips were incubated for 30 min at room temperature with 5948C, 1 min annealing at 608C, and 2 min elongation at 728C) with
mg/ml anti-LAMP-1 (Pharmingen), anti-HLA-DR (Becton Dickinson),Taq polymerase (gene Amp PCR reagents kit; Perkin Elmer Cetus).
anti-DC-LAMP, or anti-HLA-DM in permeabilization medium. Rabbitb-actin RT±PCR was used as control for the efficiency of the reac-
anti-HLA-DM was raised against a peptide encoding the cyto-tion. Sense (nucleotides 99±118, 59-GCACGATGGCAGTCAAATGA)
plasmic tail of the HLA-DM b chain.and antisense (nucleotides 825±806, 59-GAAGTATCTCCGAGGTGA
After three washes, cells were incubated for 30 min with second-AA) primers were used to amplify E02B02.
ary labeled antibodies (donkey anti-mouse coupled to Texas red or
Cyanin 5 [Vector Laboratories, Burlingame,CA]), washed, incubatedProduction of Recombinant E02B02 and Generation of MAb
with mouse preimmune serum for 30 min, washed again, postfixedHuman recombinant E02B02 was expressed in E. coli as Ig fusion
with 2% paraformaldehyde, incubated for 30 min with a secondand alkaline phosphatase fusion proteins. A HindIII±XhoI fragment
primary antibody coupled to biotin, rinsed, and labeled with fluores-was derived from PCRwith E02B02 cDNA as template. The fragment
cein-conjugated streptavidin or with a second primary antibody di-was inserted into a modified form of pCDM8 (InVitrogen, Carlsbad,
rectly coupled to fluorescein. Uptake of FITC-Dextran (MolecularCA). This vector had the pCDM8 XhoI±NotI region replaced with a
Probes, Eugene, OR) was performed for 1 hr at 378C before or afterfragment encoding human immunoglobulin G1, Fc (residues 74±768
5 hr of LPS treatment. Fixed cells were labeled with HLA-DR andof EMBL accession X70421), or mature human placental alkaline
DC-LAMP as above. Visualization of acid pH compartments wasphosphatase without its C-terminal membrane attachment domain
performed using the weakly basic amine lysotracker (Molecular(residues 301±1749 of EMBL accession U09661). Recombinant plas-
Probes) that selectively accumulates in low internal pH cellular com-mids were electroporated in COP5 cells, and after 5±7 days of cul-
partments. The cells were incubated with the lysotracker for 1 hr atture, Ig fusion protein (z50 kDa) was purified from supernatant by
378C and fixed. Coverslips were mounted onto glass slides withHiTrapA chromatography (Pharmacia, Upsalla, Sweden). E02B02-
Fluoromount (Southern Biotechnology Associates, Birmingham,alkaline phosphatase recombinant fusion protein was purified by
AL). Confocal microscopy was performed using the Confocal LaserDEAE anion exchange chromatography on a Zephyr-D silicium col-
Scanning Microscopy TCS 4D (Leica Lasertechnik GmbH, Heidel-umn (IBF Sepracor, Villeneuve, France).
berg, Germany) (Rovere et al., 1998).Mouse monoclonal antibodies against E02B02 were generated in
BALB/c mice as previously described (Fossiez et al., 1996), with
three successive intraperitoneal injections of Freund's adjuvant Acknowledgments
(Sigma) and 1 mg of purified E02B02 Ig fusion protein. Hybridoma
supernatants were selected on E02B02-alkaline phosphatase trans- Preliminary results were presented at the Keystone Symposia on
fected COP5. Antibody binding was revealed with peroxidase-con- Cellular and Molecular Biology of Dendritic Cells held in Santa Fe,
jugated sheep anti-mouse IgG (Biosys, CompieÁ gne, France). New Mexico, in March, 1998.
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